POSACONAZOLE

Westminster Pharmaceuticals, LLC🇺🇸 United States

FDA Page

Effective Date: Jul 20, 2023
Approval ID: 18c3b1aa-d4c3-4b08-b247-eeaa71cf6338
Products: 1 registered
Version: 2

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use POSACONAZOLE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for POSACONAZOLE DELAYED-RELEASE TABLETS. POSACONAZOLE delayed-release tablets, for oral use. Initial U.S. Approval: 2006

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.